Search Results - "BİLEN, Mehmet"

Frailty and cancer: Implications for oncology surgery, medical oncology, and radiation oncology by Ethun, Cecilia G., Bilen, Mehmet A., Jani, Ashesh B., Maithel, Shishir K., Ogan, Kenneth, Master, Viraj A.

“…Answer questions and earn CME/CNE The concept of frailty has become increasingly recognized as one of the most important issues in health care and health…”
Get full text

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study by Choueiri, Toni K, Shyr, Yu, Grivas, Petros, Thompson, Michael A, Bilen, Mehmet A, Bouganim, Nathaniel, Doroshow, Deborah B, Egan, Pamela C, Elkrief, Arielle, Farmakiotis, Dimitrios, Glover, Michael J, Griffiths, Elizabeth A, Gulati, Anthony P, Gupta, Shilpa, Hsu, Emily, Lemmon, Christopher A, Lewis, Colleen, Masters, Tyler, Mesa, Ruben A, Morgans, Alicia K, Reynolds, Kerry, Rosen, Lane R, Schmidt, Andrew, Shaya, Justin A, Wulff-Burchfield, Elizabeth, Xie, Zhuoer, Yu, Peter P, Zubiri, Leyre, Warner, Jeremy L, Acoba, Jared D., Agarwal, Neeraj, Ahmad, Syed, Ajmera, Archana, Angevine, Anne H., Azad, Nilo, Barnholtz-Sloan, Jill, Barrow, Briana, Boland, Genevieve, Bonnen, Mark, Bouchard, Gabrielle, Busser, Fiona, Casulo, Carla, Curran, Catherine, Deeken, John, Demetri, George D., DiLullo, Sandy, Elias, Rawad, Feldman, Lawrence E., Friese, Christopher R., Fu, Paul, Gillaspie, Erin A., Giordano, Antonio, Glace, (Mary) Grace, Gurley, Michael, Halmos, Balazs, Johnson, Douglas B., Koshkin, Vadim S., Leighton, John C., Li, Xuanyi, LoRusso, Patricia, Low, Clarke A., Mansoor, Abdul-Hai, Handy Marshall, Catherine, Matar, Sara, McNair, Christopher, Mehnert, Janice M., Menon, Harry, Nagle, Sarah, Nakayama, John M., Nelson, Heather H., Nemecek, Eneida R., Nuzzo, Pier Vitale, Oberstein, Paul E., Owenby, Susie, Pasquinelli, Mary M., Revankar, Sanjay G., Rho, Young Soo, Rhodes, Terence D., Rice, Robert L., Riess, Jonathan, Routy, Bertrand, Rovito, Marc A., Saif, M. Wasif, Sanyal, Amit, Serrano, Oscar, Shah, Mansi, Shaw, Grace, Shergill, Ardaman, Stauffer, Karen, Stratton, Jamie, Stratton, Catherine, Subbiah, Vivek, Tannir, Nizar M., Van Allen, Eli, Verma, Amit K., Vikas, Praveen, Weiss, Matthias, Wise-Draper, Trisha, Wood, William A., Zacks, Rosemary

“…Data on patients with COVID-19 who have cancer are lacking. Here we characterise the outcomes of a cohort of patients with cancer and COVID-19 and identify…”
Get full text

Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study by Martínez Chanzá, Nieves, Xie, Wanling, Asim Bilen, Mehmet, Dzimitrowicz, Hannah, Burkart, Jarred, Geynisman, Daniel M, Balakrishnan, Archana, Bowman, I Alex, Jain, Rohit, Stadler, Walter, Zakharia, Yousef, Narayan, Vivek, Beuselinck, Benoit, McKay, Rana R, Tripathi, Abhishek, Pachynski, Russell, Hahn, Andrew W, Hsu, JoAnn, Shah, Sumit A, Lam, Elaine T, Rose, Tracy L, Mega, Anthony E, Vogelzang, Nicholas, Harrison, Michael R, Mortazavi, Amir, Plimack, Elizabeth R, Vaishampayan, Ulka, Hammers, Hans, George, Saby, Haas, Naomi, Agarwal, Neeraj, Pal, Sumanta K, Srinivas, Sandy, Carneiro, Benedito A, Heng, Daniel Y C, Bosse, Dominick, Choueiri, Toni K, Harshman, Lauren C

“…Cabozantinib is approved for patients with metastatic renal cell carcinoma on the basis of studies done in clear-cell histology. The activity of cabozantinib…”
Get full text

Enfortumab Vedotin With or Without Pembrolizumab in Cisplatin-Ineligible Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer by O'Donnell, Peter H, Milowsky, Matthew I, Petrylak, Daniel P, Hoimes, Christopher J, Flaig, Thomas W, Mar, Nataliya, Moon, Helen H, Friedlander, Terence W, McKay, Rana R, Bilen, Mehmet A, Srinivas, Sandy, Burgess, Earle F, Ramamurthy, Chethan, George, Saby, Geynisman, Daniel M, Bracarda, Sergio, Borchiellini, Delphine, Geoffrois, Lionnel, Maroto Rey, Jose Pablo, Ferrario, Christiano, Carret, Anne-Sophie, Yu, Yao, Guseva, Maria, Homet Moreno, Blanca, Rosenberg, Jonathan E

“…Patients with locally advanced or metastatic urothelial cancer (la/mUC) who are ineligible for cisplatin-based therapy have limited first-line (1L) treatment…”
Get full text

Treatment patterns for patients with BRCA1/2-positive metastatic castration-resistant prostate cancer by Bilen, Mehmet A, Khilfeh, Ibrahim, Rossi, Carmine, Morrison, Laura, Diaz, Lilian, Hilts, Annalise, Lefebvre, Patrick, Pilon, Dominic, George, Daniel J

“…Patients with BRCA-positive metastatic castration-resistant prostate cancer (mCRPC) have an aggressive disease course. This study aimed to describe real-world…”
Get full text

Phase II Study of Nivolumab and Salvage Nivolumab/Ipilimumab in Treatment-Naive Patients With Advanced Clear Cell Renal Cell Carcinoma (HCRN GU16-260-Cohort A) by Atkins, Michael B, Jegede, Opeyemi A, Haas, Naomi B, McDermott, David F, Bilen, Mehmet A, Stein, Mark, Sosman, Jeffrey A, Alter, Robert, Plimack, Elizabeth R, Ornstein, Moshe, Hurwitz, Michael, Peace, David J, Signoretti, Sabina, Denize, Thomas, Cimadamore, Alessia, Wu, Catherine J, Braun, David, Einstein, David, Catalano, Paul J, Hammers, Hans

“…To determine the value of tumor cell programmed death-ligand 1 (PD-L1) expression as a predictive biomarker of nivolumab monotherapy efficacy in…”
Get full text

Impact of Naples Prognostic Score at Admission on In-Hospital and Follow-Up Outcomes Among Patients with ST-Segment Elevation Myocardial Infarction by Erdogan, Aslan, Genc, Omer, Ozkan, Eyüp, Goksu, Muhammed M., Ibisoglu, Ersin, Bilen, Mehmet N., Guler, Ahmet, Karagoz, Ali

“…The Naples prognostic score (NPS) consists of cholesterol level, albumin concentration, lymphocyte-to-monocyte and neutrophil-to-lymphocyte ratios and reflects…”
Get full text

Activity of cabozantinib after immune checkpoint blockade in metastatic clear-cell renal cell carcinoma by McGregor, Bradley A., Lalani, Aly-Khan A., Xie, Wanling, Steinharter, John A., E. Bakouny, Ziad, Martini, Dylan J., Fleischer, Justin H., Abou-Alaiwi, Sarah, Nassar, Amin, Nuzzo, Pier V., Kaymakcalan, Marina D., Braun, David A., Wei, Xiao X., Harshman, Lauren C., Bilen, Mehmet A., Choueiri, Toni K.

“…Cabozantinib is approved for the first and subsequent line treatment of metastatic clear-cell renal cell carcinoma (ccRCC) based on trials in which most…”
Get full text

Characterization of metastatic urothelial carcinoma via comprehensive genomic profiling of circulating tumor DNA by Agarwal, Neeraj, Pal, Sumanta K., Hahn, Andrew W., Nussenzveig, Roberto H., Pond, Gregory R., Gupta, Sumati V., Wang, Jue, Bilen, Mehmet A., Naik, Gurudatta, Ghatalia, Pooja, Hoimes, Christopher J., Gopalakrishnan, Dharmesh, Barata, Pedro C., Drakaki, Alexandra, Faltas, Bishoy M., Kiedrowski, Lesli A., Lanman, Richard B., Nagy, Rebecca J., Vogelzang, Nicholas J., Boucher, Kenneth M., Vaishampayan, Ulka N., Sonpavde, Guru, Grivas, Petros

“…BACKGROUND Biomarker‐guided clinical trials are increasingly common in metastatic urothelial carcinoma (mUC), yet patients for whom contemporary tumor tissue…”
Get full text

Clinical and Economic Outcomes in Patients With Metastatic Urothelial Carcinoma Receiving First-Line Systemic Treatment (the IMPACT UC I Study) by Bilen, Mehmet A, Robinson, Scott B, Schroeder, Amy, Peng, Jing, Kim, Ruth, Liu, Frank X, Bhanegaonkar, Abhijeet

“…Abstract Background The IMPACT UC I study assessed real-world treatment patterns, outcomes, healthcare resource utilization (HCRU), and costs in patients with…”
Get full text

The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced‐stage cancer treated with immunotherapy by Bilen, Mehmet A., Martini, Dylan J., Liu, Yuan, Lewis, Colleen, Collins, Hannah H., Shabto, Julie M., Akce, Mehmet, Kissick, Haydn T., Carthon, Bradley C., Shaib, Walid L., Alese, Olatunji B., Pillai, Rathi N., Steuer, Conor E., Wu, Christina S., Lawson, David H., Kudchadkar, Ragini R., El‐Rayes, Bassel F., Master, Viraj A., Ramalingam, Suresh S., Owonikoko, Taofeek K., Harvey, R. Donald

“…Background Optimal prognostic and predictive biomarkers for patients with advanced‐stage cancer patients who received immunotherapy (IO) are lacking…”
Get full text

Quantitative Analysis of Right Atrial Functions by 2D‐Speckle Tracking Echocardiography During Healthy Pregnancy by Guler, Yeliz, Karagoz, Ali, Inan, Duygu, Sonsoz, Mehmet R., Bilen, Mehmet N., Guler, Ahmet, Kirma, Cevat

“…Background The role of speckle tracking in the assessment of right atrial (RA) deformation parameters has not been investigated yet. The purpose of this…”
Get full text

Retrospective Study of Bleeding Risk with Concomitant Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor and Anticoagulation by Sivakumar, Akhilesh, Caulfield, Sarah E., Zhang, Chao, Goyal, Subir, Bilen, Mehmet A., Beardslee, Tyler J.

“…Background Patients with cancer are at higher risk for venous thromboembolism (VTE) and bleeding, in turn complicating anticoagulant therapy. An added…”
Get full text

Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies by McGregor, Bradley Alexander, Campbell, Matthew T., Xie, Wanling, Farah, Subrina, Bilen, Mehmet A., Schmidt, Andrew L., Sonpavde, Guru P., Kilbridge, Kerry L., Choudhury, Atish D., Mortazavi, Amir, Shah, Amishi Y., Venkatesan, Aradhana M., Bubley, Glenn J., Siefker‐Radtke, Arlene O., McKay, Rana R., Choueiri, Toni K.

“…Background In this multicenter, single‐arm, multicohort, phase 2 trial, the efficacy of nivolumab and ipilimumab was evaluated in patients with advanced rare…”
Get full text

Cytoreductive surgery, systemic treatment, genetic evaluation, and patient perspective in a young adult with metastatic renal cell carcinoma by Nicaise, Edouard H., Yildirim, Ahmet, Sheth, Swapnil, Richter, Ellen, Daneshmand, Mani A., Maithel, Shishir K., Ogan, Kenneth, Bilen, Mehmet A., Master, Viraj A.

Get full text

Impact of performance status on treatment outcomes: A real‐world study of advanced urothelial cancer treated with immune checkpoint inhibitors by Khaki, Ali Raza, Li, Ang, Diamantopoulos, Leonidas N., Bilen, Mehmet A., Santos, Victor, Esther, John, Morales‐Barrera, Rafael, Devitt, Michael, Nelson, Ariel, Hoimes, Christopher J., Shreck, Evan, Assi, Hussein, Gartrell, Benjamin A., Sankin, Alex, Rodriguez‐Vida, Alejo, Lythgoe, Mark, Pinato, David J., Drakaki, Alexandra, Joshi, Monika, Isaacsson Velho, Pedro, Hahn, Noah, Liu, Sandy, Alonso Buznego, Lucia, Duran, Ignacio, Moses, Marcus, Jain, Jayanshu, Murgic, Jure, Baratam, Praneeth, Barata, Pedro, Tripathi, Abhishek, Zakharia, Yousef, Galsky, Matthew D., Sonpavde, Guru, Yu, Evan Y., Shankaran, Veena, Lyman, Gary H., Grivas, Petros

“…Background Immune checkpoint inhibitors (ICIs) represent an appealing treatment for patients with advanced urothelial cancer (aUC) and a poor performance…”
Get full text

Studying the effect of different operation parameters on the grinding energy efficiency in laboratory stirred mill by Akkaya, Barış, Toroğlu, İhsan, Bilen, Mehmet

“…[Display omitted] In this study, considering different operational parameters for stirred media mill, change in specific energy was compared to the change in…”
Get full text

Cabozantinib for the treatment of patients with metastatic non-clear cell renal cell carcinoma: A retrospective analysis by Campbell, Matthew T., Bilen, Mehmet A., Shah, Amishi Y., Lemke, Emily, Jonasch, E., Venkatesan, A.M., Altinmakas, E., Duran, C., Msaouel, Pavlos, Tannir, N.M.

“…Cabozantinib prolongs overall survival (OS) and progression-free survival (PFS) in patients with metastatic clear cell renal cell carcinoma (RCC) that…”
Get full text

Circulating Tumor DNA in Genitourinary Cancers: Detection, Prognostics, and Therapeutic Implications by Gerke, Margo B, Jansen, Caroline S, Bilen, Mehmet A

“…CtDNA is emerging as a non-invasive clinical detection method for several cancers, including genitourinary (GU) cancers such as prostate cancer, bladder…”
Get full text

"Reply to Letter to the Editor for Research Paper Entitled : Impact of Naples prognostic Score at Admission on In-Hospital and Follow-Up Outcomes Among Patients With ST-Segment Elevation Myocardial Infarction" by Erdogan, Aslan, Genc, Omer, Ozkan, Eyüp, Goksu, Muhammed M, Ibisoglu, Ersin, Bilen, Mehmet N, Guler, Ahmet, Karagoz, Ali

Get full text